'Tis the season for biopharma fundraising, as Cowen closes $493M fund
Another healthcare venture fund is surfeit with capital, as the season for fundraising motors on amid the coronavirus pandemic.
Cowen Healthcare Investments (CHI), an investment manager affiliated with the investment bank Cowen, has closed its third fund, raising $493 million, a meaty $93 million above its original target. Founded in 2012, CHI focuses its investments in established biopharma, diagnostics and digital health companies and has injected funds in 38 private companies thus far.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.